Sunday - August 09, 2026

Category Archives: Pharmaceuticals & Biotech

Healthcare BPO Market to Reach $735.05 Billion by 2031, Driven by Administrative Efficiency Needs and AI-Enabled Outsourcing

Healthcare BPO Market by Life Science (Drug Discovery, Clinical Trial, Regulatory), Provider (RCM, Clinical Documentation, Patient Engagement), Payer (Billing, Claims), Technology (BPaaS, AI-enabled), Model (Onshore, Offshore) – Global Forecast to 2031 – Global Forecast to 2031 According to MarketsandMarkets™, The … Continue reading →

Cancer Biomarkers Market to Reach $54.48 Billion by 2032, Driven by Rising Cancer Burden and Advancements in Precision Medicine

Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), Enduser, and Region – Global Forecast to 2032 According to MarketsandMarkets™, The global cancer biomarkers market is projected to … Continue reading →

Hospital Information Systems Market to Reach $116.75 Billion by 2030, Driven by AI Integration and Cloud Adoption

Hospital Information Systems Market by Component (Service, Software), product type (EHR, CDSS, Specialty, Diagnostic, Pharmacy, Quality, SCM, PHM, RCM, Data Analytics, Telehealth), Deployment (On-Premises, Cloud-Based), Region – Global Forecast to 2030 According to MarketsandMarkets™, The global Hospital Information Systems Market … Continue reading →

Digital X-ray Market to Reach $7.50 Billion by 2031, Driven by Healthcare Modernization and AI-Enabled Imaging

Digital X-ray Market By Portability (Fixed, Portable), Applications (General, Dental, Mammography, Cancer, Fluoroscopy), Technology (Direct, Computed), System (Retrofit, New), End Users, Price Range, Type, and Region – Global Forecast to 2031 According to MarketsandMarkets™, The global Digital X-ray Market is … Continue reading →

Bull Finder: IBRX, ANY, GTE, JLHL Plus More Surging Stocks Inside

Aug. 5, 2026 – Investor interest remains elevated across the small-cap and mid-cap markets as several companies announced significant corporate developments ranging from record revenue growth and strategic acquisitions to major institutional investments and transformational asset sales. The following companies … Continue reading →

Gene Therapy Market to Reach $36.55 Billion by 2032, Driven by Rising Demand for Curative Treatments and Expanding Clinical Pipeline

Gene Therapy Market by Type (Gene silencing), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Gene Type (Receptors, Cytokine), Therapeutic Area (Oncology, Neurology), Delivery Method (In-Vivo, Ex-Vivo), RoA (IV) – Global Forecast to 2032 According to MarketsandMarkets™,The global gene therapy market is … Continue reading →